Işıl İnanır

708 total citations
36 papers, 460 citations indexed

About

Işıl İnanır is a scholar working on Dermatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Işıl İnanır has authored 36 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 13 papers in Epidemiology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Işıl İnanır's work include Nail Diseases and Treatments (7 papers), Cancer and Skin Lesions (4 papers) and Autoimmune Bullous Skin Diseases (4 papers). Işıl İnanır is often cited by papers focused on Nail Diseases and Treatments (7 papers), Cancer and Skin Lesions (4 papers) and Autoimmune Bullous Skin Diseases (4 papers). Işıl İnanır collaborates with scholars based in Türkiye, United Kingdom and United States. Işıl İnanır's co-authors include Kamer Gündüz, Gülsüm Gençoğlan, Serap Öztürkcan, Gönül Dinç, Aylin Türel Ermertcan, Nalan Neşe, Peyker Temız, Tuğrul Dereli, Seda Vatansever and Önder Şahin and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Dermatology and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

Işıl İnanır

33 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Işıl İnanır Türkiye 13 211 132 77 59 54 36 460
Paul Devakar Yesudian United Kingdom 13 252 1.2× 144 1.1× 40 0.5× 97 1.6× 90 1.7× 74 538
Rocío Orozco‐Topete Mexico 13 206 1.0× 154 1.2× 42 0.5× 83 1.4× 116 2.1× 32 504
Emel Feti̇l Türkiye 13 198 0.9× 52 0.4× 55 0.7× 66 1.1× 70 1.3× 42 435
Shekhar Neema India 10 192 0.9× 107 0.8× 55 0.7× 61 1.0× 33 0.6× 109 443
Seray Külcü Çakmak Türkiye 15 256 1.2× 165 1.3× 46 0.6× 125 2.1× 83 1.5× 87 693
Fatih Göktay Türkiye 14 189 0.9× 216 1.6× 24 0.3× 102 1.7× 79 1.5× 58 480
Omid Zargari Iran 12 113 0.5× 69 0.5× 42 0.5× 63 1.1× 62 1.1× 39 380
Alexandre Carlos Gripp Brazil 11 91 0.4× 93 0.7× 48 0.6× 89 1.5× 135 2.5× 42 383
N. Doss Tunisia 14 335 1.6× 108 0.8× 43 0.6× 51 0.9× 49 0.9× 55 585
Ayşe Tülin Mansur Türkiye 11 133 0.6× 150 1.1× 32 0.4× 66 1.1× 58 1.1× 45 362

Countries citing papers authored by Işıl İnanır

Since Specialization
Citations

This map shows the geographic impact of Işıl İnanır's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Işıl İnanır with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Işıl İnanır more than expected).

Fields of papers citing papers by Işıl İnanır

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Işıl İnanır. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Işıl İnanır. The network helps show where Işıl İnanır may publish in the future.

Co-authorship network of co-authors of Işıl İnanır

This figure shows the co-authorship network connecting the top 25 collaborators of Işıl İnanır. A scholar is included among the top collaborators of Işıl İnanır based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Işıl İnanır. Işıl İnanır is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gençoğlan, Gülsüm, et al.. (2017). Evaluation of sequential effect of isotretinoin on the haematological parameters in patients with acne vulgaris. Cutaneous and Ocular Toxicology. 37(2). 139–142. 16 indexed citations
2.
Ermertcan, Aylin Türel, et al.. (2012). Hyperbaric oxygen therapy for the management of chronic wounds. Cutaneous and Ocular Toxicology. 32(1). 72–77. 15 indexed citations
3.
Gündüz, Kamer, et al.. (2012). Efficacy of 5% imiquimod cream in a patient with classic Kaposi sarcoma. Journal of Dermatological Case Reports. 6(2). 52–3. 6 indexed citations
4.
Gündüz, Kamer, et al.. (2012). Expression of Nuclear Factor Kappa B and Survivin in Psoriasis. SHILAP Revista de lepidopterología. 2012. 1–4. 7 indexed citations
5.
Gençoğlan, Gülsüm, Işıl İnanır, & Aylin Türel Ermertcan. (2011). Hypopyon‐like features: new dermoscopic criteria in the differential diagnosis of cutaneous lymphangioma circumscriptum and haemangiomas?. Journal of the European Academy of Dermatology and Venereology. 26(8). 1023–1025. 17 indexed citations
6.
Gençoğlan, Gülsüm, Işıl İnanır, & Kamer Gündüz. (2010). Therapeutic Hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatologic Therapy. 23(2). 194–198. 40 indexed citations
7.
Gençoğlan, Gülsüm, et al.. (2010). Primary cutaneous anaplastic CD30+large-cell lymphoma that completely regressed after incisional skin biopsy. Cutaneous and Ocular Toxicology. 30(2). 163–166. 1 indexed citations
8.
Gençoğlan, Gülsüm, et al.. (2010). Acral Amelanotic Verrucous Melanoma: Dermoscopic Findings. Dermatologic Surgery. 37(1). 107–110. 5 indexed citations
9.
Gençoğlan, Gülsüm, Işıl İnanır, & Kamer Gündüz. (2009). Pyogenic Granuloma in Two Children Successfully Treated with Imiquimod 5% Cream. Pediatric Dermatology. 26(3). 366–368. 6 indexed citations
10.
Ermertcan, Aylin Türel, et al.. (2009). Acute generalized exanthematous pustulosis with lymphangitis triggered by a spider bite. Cutaneous and Ocular Toxicology. 29(1). 67–69. 8 indexed citations
11.
Gündüz, Kamer, et al.. (2006). Expression of matrix metalloproteinases (MMP‐2, MMP‐3, and MMP‐9) and fibronectin in lichen planus. Journal of Cutaneous Pathology. 33(8). 545–550. 27 indexed citations
12.
Örgüç, Şebnem, et al.. (2006). A case of mycetoma successfully treated with itraconazole and co‐trimoxazole. Mycoses. 49(5). 436–438. 12 indexed citations
13.
Gündüz, Kamer, et al.. (2006). Examination of bcl‐2 and p53 expressions and apoptotic index by TUNEL method in psoriasis. Journal of Cutaneous Pathology. 33(12). 788–792. 17 indexed citations
14.
Gündüz, Kamer, et al.. (2005). Efficacy of Terbinafine 1% Cream on Seborrhoeic Dermatitis. The Journal of Dermatology. 32(1). 22–25. 13 indexed citations
15.
Şahin, Mustafa Turhan, et al.. (2003). Inguinal Keratotic Basal Cell Carcinoma Mimicking Giant Solitary Trichoepithelioma. The Journal of Dermatology. 30(5). 395–399. 7 indexed citations
16.
Ermertcan, Aylin Türel, et al.. (2003). Postadolesan aknenin akne spektrumu içindeki yeri. eArsiv - Adu (Adnan Menderes University). 4(1). 5–8. 1 indexed citations
17.
Öztürkcan, Serap, et al.. (2002). Akne Vulgarisli Hastalarda Yaşam Kalitesi. 12(3). 131–134. 2 indexed citations
18.
İnanır, Işıl. (2002). Erythema multiforme associated with blister beetle dermatitis. Contact Dermatitis. 46(3). 175–175. 9 indexed citations
19.
İnanır, Işıl, et al.. (2001). Granuloma faciale with extrafacial lesions.. British Journal of Dermatology. 145(2). 360–362. 20 indexed citations
20.
Aktan, Şebnem, et al.. (1998). Reproducibility of the Finn Chamber<sup>®</sup> Nickel Patch Test in Two Different Phases of the Ovulatory Menstrual Cycle. Dermatology. 197(3). 235–237. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026